Clinical Characteristics and Outcomes of RRHL treated with BV in Thailand
- Conditions
- Relapsed or Refractory Hodgkin Lymphoma (rrHL)Hodgkin Disease
- Registration Number
- TCTR20220722003
- Lead Sponsor
- Takeda (Thailand), Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1.Patients with RRHL
2.Age 18 years and above at diagnosis of rrHL
3.Received at least two .of BV prior to the date of site initiation and stopped or discontinued BV at the time of data extraction
Exclusion Criteria
1.Patients who have participated in an interventional clinical trial at any stage of their treatment of rrHL
2.Patients who are on BV treatment at the time of chart data extraction
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival (PFS) From first received treatment to first documentation of relapse or disease progression or death, censored at date of site initiation Length of time (month)
- Secondary Outcome Measures
Name Time Method patient demographic and clinical characteristics At enrollment Case record form